LRP6 and breast cancer: In this study, we utilized MDA-MB-231 and HCC38 cells to evaluate the canonical WNT-signaling pathway in triple negative (TN) breast cancers since this pathway is activated evaluated by LRP6 expression [26], suggesting that the WNT-signaling pathway is activated in these cell lines.